전체 글 (819) 썸네일형 리스트형 Alzheimer’s Disease Market Analysis As per the Alzheimer’s Association, more than 5 million people in the United states are living with Alzheimer’s Disease, and by 2050, the prevalence is projected to propel to nearly 14 million people. Alzheimer’s is the 6th leading cause of death in the USA, it causes more deaths than Prostate and Breast cancer combined. Women are at a higher risk of developing Alzheimer’s Disease. About two-thi.. Technological Aids to Assist Alzheimer's Patients Alzheimer’s is a progressive neurological disorder associated with the degeneration of brain cells with time. The progression of disease causes severe impact on the memory, thinking, and overall behavior of the individual, in fact at the later phases it becomes even challenging to perform simple day to day tasks for the affected person. As per World Health Organization, “nearly 50 million people.. Dilated Cardiomyopathy Market Analysis and Forecast The total prevalent cases of Dilated Cardiomyopathy in the 7MM are expected to be 2,523,808 in 2020. The Dilated Cardiomyopathy market is expected to grow with a CAGR of 13.1% in the 7MM during the study period (2017–2030). Increasing prevalence rate, increased healthcare spending, and emerging treatment options are some of the key factors expected to drive the Dilated Cardiomyopathy market in t.. Prostate Cancer Market Analysis The total prevalent cases of Prostate Cancer in the 7MM is expected to be 7,494,882 in 2020. The market size of Prostate Cancer is expected to grow at a CAGR of 8.1% during the study period 2017-2030. Increasing use of biomarker testing, rising geriatric population and high prevalence rate of prostate cancer, surge in awareness regarding the treatment of prostate cancer, increase in demand for p.. Recent pharma happenings for Alnylam, Astellas, and Evotec Alnylam Releases Phase III ILLUMINATE-A Trial Results Testing Lumasiran for PH1 Alnylam's Lumasiran is an experimental RNA interference therapy that targets hydroxy acid oxidase 1 (HAO1) responsible for the production of the glycolate oxidase (GO), thus blocking the production of oxalate. AstraZeneca's Blood Cancer Drug Calquence Might be the New Weapon to Fight COVID-19 The preliminary research.. Dilated Cardiomyopathy Market According to DelveInsight’s analysis, Dilated Cardiomyopathy prevalence was recorded to be 2,486,633 in 2017, which is expected to be 2,523,808 by 2020 and grow by 2030. The United States accounted for the highest Dilated Cardiomyopathy prevalence in the seven major markets. The Dilated Cardiomyopathy Market Size in the 7MM is expected to increase from USD 244 Million in 2017 by 2030. The key co.. Prostate Cancer Market As per American Cancer Society (2019), “One in Nine men in the United States is diagnosed with prostate cancer at some point in their lives”. According to DelveInsight’s Prostate Cancer Epidemiological analysis, by 2020, a total of 7,494,882 males will be diagnosed with prostate cancer in the Seven Major Markets, and the United States alone will account for 3,478,728 Prostate Cancer prevalent ca.. HR Positive/ HER2 Negative Breast Cancer Market HR-positive/HER2-negative breast cancer is the most common form of breast cancer and also accounts for a higher percentage of all breast cancers. HR-positive cancer is usually treated with hormone therapies or a combination of hormone therapies with targeted therapy to help stop tumor growth. A number of classes of anti estrogenic agents available for patients with early, advanced, or metastatic.. 이전 1 ··· 87 88 89 90 91 92 93 ··· 103 다음
